[1]郭超,张兴彩,王卫国,等.基于网络药理学探讨“山药-杜仲”药对治疗骨质疏松症的作用机制[J].西部中医药,2024,37(02):48-53.[doi:10.12174/j.issn.2096-9600.2024.02.11]
　GUO Chao,ZHANG Xingcai,WANG Weiguo,et al.Mechanism of Chinese Yam-Duzhong in the Treatment of Osteoporosis Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2024,37(02):48-53.[doi:10.12174/j.issn.2096-9600.2024.02.11]
点击复制

基于网络药理学探讨“山药-杜仲”药对治疗骨质疏松症的作用机制
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
37
期数:
2024年02期
页码:
48-53
栏目:
二次研究
出版日期:
2024-02-15

文章信息/Info

Title:
Mechanism of Chinese Yam-Duzhong in the Treatment of Osteoporosis Based on Network Pharmacology
作者:
郭超1, 张兴彩2, 王卫国2, 刘晓晨2, 吕文学2, 蔡余力2
1.山东中医药大学，山东 济南 250355
2.山东中医药大学附属医院，山东 济南 250014
Author(s):
GUO Chao1, ZHANG Xingcai2, WANG Weiguo2, LIU Xiaochen2, LYU Wenxue2, CAI Yuli2
1.Shandong University of Traditional Chinese Medicine, Jinan 250355, China
2.Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250014, China
关键词:
骨质疏松症; 网络药理学; 山药; 杜仲; 益肾健脾
Keywords:
osteoporosis; network pharmacology; Chinese yam; benefiting-kidney invigorating-spleen
分类号:
R322.7+1
DOI:
10.12174/j.issn.2096-9600.2024.02.11
文献标志码:
A
摘要:
目的运用网络药理学探索益肾健脾中药“山药-杜仲”药对治疗骨质疏松症的作用机制。 方法通过中药数据库检索“山药-杜仲”的活性成分及相关作用靶点，运用Cytoscape 3.7.2制作“活性成分-靶点”网络图。利用GeneCards数据库搜集骨质疏松症相关靶点，将药物靶点与疾病靶点进行映射，取交集靶点上传STRING 11.0数据库构建蛋白互作网络，将该网络导入Cytoscape 3.7.2进一步加工分析。将关键靶点上传至Metascape平台进行GO富集分析与KEGG通路富集分析。 结果共获得山药和杜仲活性成分38个，对应靶点225个，骨质疏松症相关靶点1376个。药物-疾病作用核心靶点80个，包括白蛋白、白细胞介素6、腺苷酸激酶同工酶1、血管内皮生长因子、抑癌基因p53、肿瘤坏死因子、基质金属蛋白酶9等。KEGG富集分析显示其作用于骨质疏松症的潜在通路主要包括糖尿病并发症的AGE-RAGE信号通路、T细胞受体信号通路、p53信号通路、TGF-β信号通路、HIF-1信号通路等。 结论本研究初步探讨了益肾健脾药对“山药-杜仲”对骨质疏松症的“多通路、多靶点”作用机制，为进一步探索益肾健脾法治疗骨质疏松症提供研究思路与理论基础。
Abstract:
ObjectiveTo explore the mechanism of benefiting-kidney invigorating-spleen herbs Chinese yam-Duzhong (eucommiae cortex) in the treatment of osteoporosis using network pharmacology. MethodsThe active ingredients and related targets of Chinese yam-Duzhong were searched by TCM database (TCMSP), and the network diagram of "active ingredients-targets" was made by using Cytoscape3.7.2. The targets related to osteoporosis were collected using GeneCards database, the intersection targets were obtained by mapping the drug targets to the disease targets, and uploaded to STRING 11.0 database to build PPI, which was imported into Cytoscape 3.7.2, processed and analyzed. The key targets were uploaded to Metascape platform to carry out GO enrichment analysis and KEGG pathway enrichment analysis. ResultsThe study obtained 38 active ingredients from Chinese yam and Duzhong, 225 corresponding targets and 1376 targets related to the disease. There were 80 core targets of medicine-disease action, including albumin, interleukin 6 (IL6), adenylate kinase isoenzyme 1, vascular endothelial growth factor (VEGF), tumor suppressor p53, tumour necrosis factor, MMP9 and others. KEGG enrichment analysis displayed that the potential pathway acting on osteoporosis mainly included AGE-RAGE signal pathways of diabetic complication, T cell receptor signal pathway, p53 signal pathway, TGF-β signal pathway and HIF-1 signal pathway. ConclusionThis study has primarily discussed the "multi-pathway, multi-target" mechanism of Chinese yam-Duzhong, the couplet medicines which could benefit the kidney and invigorate spleen, in the treatment of osteoporosis, wishing to provide the research thinking and theoretical foundation for further exploration into the treatment of osteoporosis by benefiting-kidney invigorating-spleen method.

相似文献/References:

[1]谢栋,陈大军,马国亮,等.原发性骨质疏松症的骨密度与中医脏腑辨证的相关性研究*[J].西部中医药,2015,28(02):82.
[2]梁敏.绝经后骨质疏松症42例护理体会[J].西部中医药,2015,28(12):129.
[3]张彩凤,程卫东△,王彩霞,等.玫参胶囊治疗围绝经期骨质疏松症60例[J].西部中医药,2012,25(05):16.
　ZHANG Cai-feng,CHENG Wei-dong,WANG Cai-xia,et al.MeiShen Capsule in Treating 60 Cases of Menopausal Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2012,25(02):16.
[4]张德宏,李晶.老年骨质疏松症的病因病机及防治原则探析[J].西部中医药,2013,26(03):90.
　ZHANG Dehong,LI Jing.The Etiology, Pathogenesis and Prevention Principles of Senile Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2013,26(02):90.
[5]李晶,宋敏△,罗晓,等.淫羊藿总黄酮对去势大鼠股骨骨组织形态学及生物力学的影响*[J].西部中医药,2014,27(07):13.
　LI Jing,SONG Min,LUO Xiao,et al.Effects of Total Flavonoids of Epimedium on Biodynamics and Bone Morphological Metrology of Ovariectomized Rats[J].Western Journal of Traditional Chinese Medicine,2014,27(02):13.
[6]李非,李红专,叶丙霖.原发性骨质疏松症的中医药研究现状[J].西部中医药,2016,29(03):136.
　LI Fei,LI Hongzhuan,YE Binlin.Research Status of Primary Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2016,29(02):136.
[7]王继宏,杨鹏玲.柴芍抗松汤治疗老年原发性骨质疏松症伴抑郁39例[J].西部中医药,2018,31(10):74.
　WANG Jihong,YANG Pengling.ChaiShao KangSong Decoction in Treating 39 Senile Patients Suffering Primary Osteoporosis Accompanying Depression[J].Western Journal of Traditional Chinese Medicine,2018,31(02):74.
[8]张长彪,彭冉东,赵军,等.益肾地黄汤联合利塞膦酸钠治疗肾阳虚型绝经后骨质疏松症45例[J].西部中医药,2017,30(04):1.
　ZHANG Changbiao,PENG Randong,ZHAO Jun,et al.YiShen Dihuang Tang Combined with Risedronate Sodium in the Treatment for 45 Cases of Postmenopausal Osteoporosis of Kidney Yang Deficiency Type[J].Western Journal of Traditional Chinese Medicine,2017,30(02):1.
[9]董林,雷宁波,邢涛,等.损伤胶囊对绝经后骨质疏松症患者疼痛、骨密度及骨代谢生化指标的影响[J].西部中医药,2017,30(11):8.
　DONG Lin,LEI Ningbo,XING Tao,et al.The Effects of Damage Capsules on the Pain, Bone Mineral Density and Biochemical Markers of Bone Metabolism of Postmenopausal Osteoporosis Patients[J].Western Journal of Traditional Chinese Medicine,2017,30(02):8.
[10]马风英.仙灵骨葆胶囊联合甲氨蝶呤治疗类风湿性关节炎继发骨质疏松症37例[J].西部中医药,2018,31(02):98.
　MA Fengying.XianLing GuBao Capsules Combined with Methotrexate in Treating 37 Rheumatiod Arthritis Patients with Secondary Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2018,31(02):98.

备注/Memo

备注/Memo:
郭超（1996—），男，硕士学位。研究方向：骨与关节疾病临床和基础研究。山东省自然科学基金面上项目（ZR2020MH351）；山东省2019—2020年度中医药科技发展计划项目（2019-0084）。
更新日期/Last Update: 2024-02-15